Clinical trial
Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell…
NCT00186810 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186810 |
|---|---|
| Title | Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease |
| Official title | Allogeneic Stem Cell Transplantation From HLA/MLC Genotype Identical Donors for Patients With High Risk Sickle Cell Disease |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease |
| Intervention type | Drug, Procedure |
| Interventions | Busulfan, Cyclophosphamide, Horse ATG, Allogeneic stem cell transplant |
| Enrollment | 15 |
| Start date | Dec 1, 1992 |
| Primary completion | Feb 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | May 29, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: